Max Reinhardt, President at Pacira BioSciences, Inc. (PCRX), sold 110 shares at $60.81 ($7K) on 2021-01-06, disclosed to the SEC on 2021-01-08.
Scheduled sale ($7k) by President under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| PCRX | SELL | 2023-06-07 | $83K | — | Filing → |
| PCRX | SELL | 2022-10-11 | $80K | — | Filing → |
| PCRX | SELL | 2022-06-08 | $497K | — | Filing → |